• Clinical | India
  •  
  • Contact us
  • Contact us
  • Clinical | India
Pearson logo
blue-globe

Hello!

We are unable to identify your country location. Please visit our International Contacts Page to find where you can order from.

View International Contacts Page Continue to website (view only)
  • ASSESSMENTS & SOLUTIONS
    • Professional assessments

      • Product A-Z
      • Clinical Psychology Products
      • Occupational & Physical Therapy Products
      • Speech and Language Products
      • Early Childhood Products
      • PreK-16 Education and Special Needs
      • Distributed Assessments

      Digital solutions

      • Q-global
      • DALS
      • DALS for University Student Mental Health
      • Trainings

      E-downloads

      • Clinical India Product Quick Reference Guide
  • ORDERING & SUPPORT
    • Ordering

      • Prices
      • Qualification Criteria
      • Ordering
      • Product Enquiries

      Account information

      • Invoices
      • Returns

      Contact us

      • Contact us
      • International contacts
  • Home
  • Clinical Assessments
  • RBANS Update - Repeatable Battery for the Assessment of Neuropsychological Status Update

${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, order history and Q-global ordering for both accounts are now accessible via the ${winnerAccount} account. If something isn’t right, please contact us.

Repeatable Battery for the Assessment of Neuropsychological Status Update

RBANS Update

Christopher Randolph
Offering valuable enhancements, the Repeatable Battery for the Assessment of Neuropsychological Status Update® (RBANS® Update) is a brief, individually administered battery to measure cognitive decline or improvement. Guidance on using this test in your telepractice.
Repeatable Battery for the Assessment of Neuropsychological Status Update
Expand Image
  • Overview
  • Product Details
  • Q-interactive

Publication date: 2012

Age range: 12:0 - 89:11 years

Scores/interpretation: Index standard scores, sub-test standard scores, total score

Qualification level: B Additional information

Completion time: 30 minutes

Administration: Digital or Paper-and-pencil

Scoring options: Q-interactive® Administration and Scoring or Manual Scoring

Other languages: Spanish (Forms A and B)

Telepractice: Guidance on using this test in your telepractice

Although RBANS Update was originally developed with a primary focus on assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. RBANS also has utility as a screener for neurocognitive status in younger patients.

Benefits

  • Covers five domains: Immediate Memory, Visuospatial/Constructional, Language, Attention, and Delayed Memory.
  • Screen for deficits in acute-care setting and neurocognitive status in adolescents.
  • Track recovery during rehabilitation and progression of neurological disorders.
  • Use as a stand-alone “core” battery for the detection and characterization of dementia in the elderly
  • Use as a neuropsychological “screen battery” when lengthier standardization assessments are either impractical or inappropriate
  • Repeat evaluations when an alternate form is needed to control for content practice effects.
  • Identify inclusion/exclusion criteria as well as efficacy and cognitive side effects in Clinical Trials.

Features

RBANS Update provides significant improvements and is ideal for measuring change over time. It can serve as a neuropsychological “screen battery” when lengthier standardization assessments are either impractical or inappropriate.

  • Downward age extended to 12:0 years.
  • Four parallel forms: Form A offers a single set of norms based on age, gender, race, education, and geographic region, with equating studies and adjustments for Forms B-D and Spanish Form A.
  • Subtest scores now available in addition to index scores.
  • Manual updated, including new information on adolescents and a review of RBANS-specific research conducted since original publication.
     

RBANS Update on Q-interactive at a Glance:

Available With

  • Standard, Classroom, & Experiential Licenses

Subtest Pricing

  • View pricing here

Scoring and Reporting

  • Scores available on screen in qiactive.com

Materials Needed

  • View the Pricing & Ordering tab and Q-interactive page

Benefits of RBANS Update on Q-interactive

  • Screen with RBANS and drill deeper with WAIS-IV, WMS-IV, CVLT 3 and a variety of other products.
  • Administer multiple times with alternative forms to monitor progress
  • Improve accuracy and speed thanks to automated scoring
  • Standardize administration like visual cues that help you administer List Learning at the correct pace

How Can I Buy RBANS Update on Q-interactive?

New customers:

Annual Q-interactive licenses can be purchased using our online order form or by calling Customer Support at 1-800-627-7271. See the Q-interactive pricing tab for more information on license options.

Current Q-interactive customers:

If you want to add the RBANS Update to your account, visit our online order form and select the "Add test(s) to existing account" option. You may also call Customer Support at 1-800-627-7271.

Modal Qualification Level

Qualification Level

Level A

This approval level enables you to buy our assessments that require no professional degree, accreditation, organization membership, or license/certificate.

Level B

This approval level enables you to buy our assessments requiring A or B qualification levels.

Level C

This approval level enables you to buy all our assessments.

Expanded Image

Loading...

ASSESSMENTS

  • Products A-Z
  • Digital Solutions

CLINICAL LEGAL POLICIES

  • Privacy Policy
  • Legal Policies
  • Permissions and Licensing

HELP & SUPPORT

  • Contact us
  • Help articles
  • Product platform logins

ABOUT PEARSON

  • About us
  • Careers
  • Sitemap

India

  • Cookies
  • Terms of use
  • Privacy
  • Do Not Sell My Personal Information
  • Patent notice
  • Accessibility